Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common seizure drug replace magnesium to protect moms with preeclampsia?

NCT ID NCT07220902

First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 21 times

Summary

This study tests whether levetiracetam, a seizure medicine, works as well as magnesium sulfate to prevent seizures in pregnant people with severe preeclampsia (a serious high blood pressure condition). About 1,240 participants at 32 or more weeks of pregnancy will be randomly assigned to one of the two drugs. The goal is to see if levetiracetam can prevent seizures with fewer side effects than magnesium, which can cause serious reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE PREECLAMPSIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Methodist Women's Hospital

    Omaha, Nebraska, 68022, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.